Johnson & Johnson Executive Speaking At Goldman Sachs Healthcare Conference Says Psoriasis Pill Icotyde Has Roughly 4,500 Prescribers Now, DTC Campaign Is Expected Soon

Loading news article.

Johnson & Johnson Executive Speaking At Goldman Sachs Healthcare Conference Says Psoriasis Pill Icotyde Has Roughly 4,500 Prescribers Now, DTC Campaign Is Expected Soon | WAPE

Johnson & Johnson Executive Speaking At Goldman Sachs Healthcare Conference Says Psoriasis Pill Icotyde Has Roughly 4,500 Prescribers Now, DTC Campaign Is Expected Soon

Article summary

Related companies

Comments —